Clinical Trials Analysis

News

HeadaTerm’s TENS therapy provides treatment for acute migraines

WAT Medical has announced that the HeadaTerm TENS device in a clinical study reduced acute migraine pain 11.8% more than…

Are drug-sparing regimens the next step in HIV management?

Sign up to the newsletter: In Brief

Your corporate email address *

First name *

Last name *

Company name *

Job title *

I would also like to subscribe to:

Medical Technology : Medical Device Network Focus (monthly)

Thematic Take (monthly)

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close

HeadaTerm’s TENS therapy provides treatment for acute migraines

Are drug-sparing regimens the next step in HIV management?

Medical device coatings companies, equipment and market

Medical device battery manufacturers and systems

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief